Ever use was not associated with increased risk (RR = 1.0), but a significant trend was observed with increasing years of use, with users of 20 or more years being at a 50% excess risk.
← all excerpts
Menopausal oestrogens and breast cancer risk: an expanded case-control study.
1
—
—